Clinical Trial Update: A Study Of ¹²⁹XE MRI To Assess Disease Progression In Patients With COPD Treated With Or Without Azithromycin And Standard-of-Care Medications [Phase 2]

View source ↗

Summary

Phase 2 trial using 129Xe MRI to monitor COPD progression, evaluating with or without azithromycin alongside standard care. The study was terminated and results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Azithromycin (azithromycin)

Snippet

Sponsor: Genentech, Inc. | Conditions: Chronic Obstructive Pulmonary Disease | Phase 2 | Status: TERMINATED | Results posted: 2024-12-24